PP_1170x120_10-25-21

National Pharmaceutical Council (NPC)

Mallinckrodt’s Steven Romano elected NPC board chair

Mallinckrodt’s Steven Romano elected NPC board chair

WASHINGTON — The National Pharmaceutical Council (NPC) announced Thursday that Dr. Steven Romano, executive vice president and chief scientific officer, Mallinckrodt Pharmaceuticals, has been elected chair of NPC’s board of directors for 2021-2022. Dr. Romano has served on NPC’s board as vice chair for the past year. “Dr. Romano’s passion for discovering innovative medicines for

Employers embrace opportunity to increase patient access to preventive care for chronic conditions through pre-deductible coverage

Employers embrace opportunity to increase patient access to preventive care for chronic conditions through pre-deductible coverage

WASHINGTON — For people with chronic conditions, consistent medication use and access to routine health services to manage their condition is essential for maintaining a high quality of life. However, financial barriers created by outdated health insurance benefit designs can interrupt needed care for some patients. High-deductible health plans (HDHPs), for instance, feature lower-than-usual monthly

NPC appoints John O’Brien as president and CEO

NPC appoints John O’Brien as president and CEO

WASHINGTON – The National Pharmaceutical Council (NPC) announced the appointment of veteran drug pricing and health policy expert John O’Brien, as president and chief executive officer. O’Brien, who will assume the role on June 1, will be responsible for overseeing NPC’s policy research and communications capacity, partnerships with other health care organizations, and strategic vision.

NPC and Duke-Margolis Center for Health Policy name Salama Freed as 2020-22 health policy fellow

NPC and Duke-Margolis Center for Health Policy name Salama Freed as 2020-22 health policy fellow

WASHINGTON — The National Pharmaceutical Council (NPC) and Duke University’s Robert J. Margolis, MD, Center for Health Policy announced that Salama Freed, has been named the 2020-22 post-doctoral health policy fellow. The two-year fellowship position, based in Washington, D.C., is designed to bridge a persistent gap between health research and policy analysis. Dr. Freed is

PQA and NPC fund two research projects to address medication access barriers

PQA and NPC fund two research projects to address medication access barriers

ALEXANDRIA, Va.  – The Pharmacy Quality Alliance (PQA) and the National Pharmaceutical Council (NPC) announced two research grants to address barriers patients face in accessing needed medications. Researchers at The Johns Hopkins Hospital and the University of Rhode Island have each received a grant to study patients’ real-world medication access problems. The projects will leverage

PQA and NPC seek research proposals to address medication access barriers

PQA and NPC seek research proposals to address medication access barriers

ALEXANDRIA, Va.  – The Pharmacy Quality Alliance (PQA) and the National Pharmaceutical Council (NPC) announced Tuesday a request for proposals (RFP) for research projects that address barriers to medication access. The organizations are interested in commissioning research that explores quality measurement targeting improved medication access, the impact of social determinants of health and other factors on

Best ideas aren’t always (or often) from Washington

Best ideas aren’t always (or often) from Washington

Earlier this spring, the National Pharmaceutical Council (NPC) partnered with the Healthcare Leadership Council to hold town hall meetings in Raleigh, N.C., and Nashville. We asked health care leaders in those communities what really matters to them. Participants focused on the top of the health care funnel: prevention. Many thoughtful participants in those rooms felt

NPC releases new study for improving patient-reported measures in oncology

NPC releases new study for improving patient-reported measures in oncology

WASHINGTON — The National Pharmaceutical Council (NPC) and Discern Health Thursday released a study that analyzes the landscape of available patient-reported measures (PRMs) and patient-reported performance measures (PR-PMs) in oncology and offers recommendations for filling gaps in measures and removing barriers to measure implementation. The study, “Improving Patient- reported Measures in Oncology,” builds on previous

NPC’s Dubois named to Health Affairs Council on health care spending

NPC’s Dubois named to Health Affairs Council on health care spending

WASHINGTON — Leading health policy journal Health Affairs today announced the members of its Council on Health Care Spending and Value, a group of diverse health care thought leaders focused on examining the different drivers of health care spending. The National Pharmaceutical Council (NPC) is proud that NPC chief science officer and executive vice president